Label: NAPROXEN- naproxen sodium tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated August 11, 2023

If you are a consumer or patient please visit this version.

  • Active ingredient (in each tablet)

    Naproxen sodium 220 mg
    (Naproxen 200 mg) (NSAID)*

    *nonsteroidal anti-inflammatory drug

  • Purpose

    Pain reliever/ fever reducer

  • Uses

    temporarily relieves minor aches and pain due to:

    backache
    muscular aches
    minor pain of arthritis
    menstrual cramps
    headache
    toothache
    the common cold

    temporarily reduces fever

  • Warnings

    Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

    hives
    facial swelling
    asthma (wheezing)
    shock
    skin reddening
    rash
    blisters

    If an allergic reaction occurs, stop use and seek medical help right away.

    Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

    are age 60 or older
    have had stomach ulcers or bleeding problems
    take a blood thinning (anticoagulant) or steroid drug
    take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
    have 3 or more alcoholic drinks every day while using this product.
    take more or for a longer time than directed.

    Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

  • Do not use

    if you have ever had an allergic reaction to any other pain reliever / fever reducer
    right before or after heart surgery
  • Ask a doctor before use if

    the stomach bleeding warning applies to you
    you have a history of stomach problems such as heartburn
    you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke
    you are taking a diuretic
    you have problems or serious side effects from taking pain relievers or fever reducers
  • Ask a doctor or pharmacist before use if

    under a doctor's care for any serious condition
      taking any other drug
  • When using this product

    take with food or milk if stomach upset occurs
  • Stop use and ask doctor if

    you experience any of the following signs of stomach bleeding:
    feel faint
    vomit blood
    have bloody or black stools
    have a stomach pain that dose not get better
    you have symptoms of heart problems or stroke

     leg swelling  chest pain
     slurred speech  trouble breathing
     weakness in one part or side of body

    pain gets worse or lasts more than 10 days
    fever gets worse or lasts more than 3 days
    you have difficulty swallowing
    it feels like the pill is stuck in your throat
    redness or swelling is present in the painful area
    any new symptoms appear
  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional
    before use. It is especially important not to use naproxen
    sodium during the last 3 months of pregnancy unless definitely
    directed to do so by a doctor because it may cause problems in
    the unborn child or complications during delivery.

  • Keep out of reach of children

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    do not take more than directed
    the smallest effective dose should be used
    drink a full glass of water with each dose
    adults and children 12 years and older
    take 1 tablet every 8 to 12 hours while symptoms last
    for the first dose you may take 2 tablets within the first hour
    do not exceed 2 tablets in any 8 to 12 hour period
    do not exceed 3 tablets in a 24 hour period
    children under 12 years: ask a doctor
  • Storage

    Store at 20-25 oC (68-77 oF). Avoid high humidity and excessive heat above 40 0C (104 0F)
  • Other information

    each tablet contains: sodium 20 mg
     
    NDC 68788-7582-02 Bottle of 20
    NDC 68788-7582-03 Bottle of 30
    NDC 68788-7582-04 Bottle of 40
    NDC 68788-7582-06 Bottle of 60

    Repackaged by Preferred Pharmaceuticals, Inc.

  • Inactive ingredients

    croscarmellose sodium, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl
    alcohol, povidone, silicon dioxide, talc, titanium dioxide

  • Questions or comments?

    Call 1-800-540-3765

  • Principal Display Panel

    Naproxen Sodium Tab USP 220mg
  • INGREDIENTS AND APPEARANCE
    NAPROXEN 
    naproxen sodium tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-7572(NDC:57896-954)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
    POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TALC (UNII: 7SEV7J4R1U)  
    Product Characteristics
    ColorblueScoreno score
    ShapeROUNDSize10mm
    FlavorImprint Code 44;417
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-7572-220 in 1 BOTTLE; Type 0: Not a Combination Product12/27/2019
    2NDC:68788-7572-330 in 1 BOTTLE; Type 0: Not a Combination Product12/27/2019
    3NDC:68788-7572-440 in 1 BOTTLE; Type 0: Not a Combination Product12/27/2019
    4NDC:68788-7572-660 in 1 BOTTLE; Type 0: Not a Combination Product12/27/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20487201/01/2019
    Labeler - Preferred Pharmaceuticals, Inc. (791119022)
    Registrant - Preferred Pharmaceuticals, Inc. (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred Pharmaceuticals, Inc.791119022REPACK(68788-7572)